1. Nexavar: Summary of Product Characteristics, 2011, http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000690/WC500027704.pdf(accessed July 17, 2015).
2. FDA-Approval for Sorafenib Tosylate, 2013, http://www.cancer.gov/cancertopics/druginfo/fda-sorafenib-tosylate#Anchor-Thy-5667(accessed July 17, 2015).
3. Nexavar: European Public Assessment Reports (EPAR)-Scientific Discussion, 2006, http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Scientific_Discussion/human/000690/WC500027707.pdf(accessed July 17, 2015).
4. Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005